Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A realistic analysis of Amarin - before Q3:
Hate to be bringing yet again bad news to this forum - but after having thought about through the day - I have reached the conclusion - that 'presenting Sarissa and Denner for the facts' - what they are up against in Europe - gives them a better chance to turn the Ship - than keeping quiet - suppressing the truth.
----------------------------------------------
Today I decided to contact my doctor (in the mail system we have) about the possibility of her prescribing Vazkepa for me' on the basis of age - a bit to high blood pressure - and 10 kg to much weight (BMI).
Searching on the subject I came across two relevant links. The first one indicating that Vazkepa is approved and available 'on the market' in Denmark.
https://pro.medicin.dk/Medicin/Praeparater/9844
But looking a bit further down Google - pointed to a link - explaining why this drug 'dont have a chance' of ever being a succes in Denmark.
(use Google to translate):
https://laegemiddelstyrelsen.dk/da/nyheder/2022/vazkepa-faar-ikke-generelt-eller-generelt-klausuleret-tilskud/~/media/299C9E264F75408DBB14AB855F8A8FDB.ashx
--------------------------------------------------
I later remembered someone on this board actually explaining that Vazkepa i Denmark will cost - more than 24.000 Dk. a year - which in reality means Amarin might just as well - delete Denmark from its EU list all together.
In a country where the actual taxation is between 70 - and 80% - big part 'because of medical costs' in general being free - a drug not 'compensated' dont have a chance in hell of being a succes.
-----------------------------------------------------
Looking at this case - yesterday's Q3 - todays 'again' losing SP (value of Company start looking critical) - I'd say that Amarin need to focus on 'Pipe Line' - removing Vascepa from the down spiral.
Many have said before - only way to once and for all - exploid the value of the fantastic CDV results of the R-I trial - separating it from generic competition (infringement) - is to go for a Statin - IPI combo product - ASAP.
ramfan, Our hopeful expectations - that after Q3 presentation - the SP of this stock would have finally hit rock bottom - got the better of us.
As JR pointed out - there is a direct correlation with falling revenue - and the SP.
Today's stock valuation proves yet again - that promeshing outlook in the future' do not in itself move the needle north. Only cold financial facts - in the form of actual proven rise in revenue is what counts.
Marzan, Nothing about Brave - in yesterday's presentation - not a word !
And I just checked the SAY questions selected (answered) - nothing there either on Brave.
https://app.saytechnologies.com/amarin-2023-q3?sort=num_upvotes
And 'to bad' the questions 'not answered' are seemingly removed from SAY - would have been just as interesting to see those questions !
Good to see that new leadership of Amarin now finally' is updating news also on X (twitter)
https://twitter.com/Amarincorp
---------------------------------------
And a Welcome also from here' to new litigation expert Jonathan Provoost.
If he could join with Marjac, and roll back the Nevada ruling 'based on fraud' from March 2020 - I would vote for him for President' - if I lived in the US 🙂
JR, You can't have it both ways - pick one and 'stick with it' ?
-----------------------------------------------------------------------------
1: I hate Denner' - dont trust him - he is in this to screw us all !
2: I need to trust - that Sarissa and Denner - is investing in Amarin - because it is undervalued !
-------------------------------------
You spend so much time - end endless number of posts speculating on Denners motives / morals.
It is tiresome and 'non constructive' going forward.
newman, Good for you ✌️
Listening to today's conferess - looking at the accounts - I'd say you have a great chance (80-90%) of making one of the best investments of your life.
-------------------------------------
It's a bit more complicated if your gag price is above $7 - but you getting rich - decreases my loss - so its all Ok. Go Amarin 🙂
the_kube, Played a lot of ball in my youth - so understand your analogy.
The Board's gets paid via shares in the company's where they are members - that is common knowledge. These are all 'new Board members of Amarin - so of course they needed to be reimbursed for representing the company - for a start.
--------------------------------------
What did not look good before the Proxy changes - when it comes to the F4 payments in shares - were that Amarin management came out and said it were 'bonus based' - when SP at the same time fell and fell - every year. And this were mostly for Board members - who already had been paid thousand and thousand of shares for years - many who held millions already.
It is not fair - to equal that Sarissa and Denner has to 'pay' their new Board members - first year for attending the job - to the Old Amarin Board - many have been in the seats for more than a decade - and still they were awarded collectively millions of shares "in bonus!" - even the value of Amarin were ever falling.
Should Sarissa/Denner here after - 'hand out F4 bonus shares' to the new BOD - even the value (God forbid) keeps falling - then we have a situation where your criticism will be correct.
ramfan, Listening to presentation - looking at the accounts SP should end north' end of day !
Will it make it above the one dollar - hem - we just have to wait and see 🙂
JR, I'm listening to (looking at the presentation right now) -
The presentation starts when you enter the link - so you can return and watch more times if you want to - no problem 🙂
Here link for Webcast presentation:
https://www.webcaster4.com/Player/Index?webcastId=49172&g=8b52f65a-2fca-484a-8631-23b6d3bf1bac&uid=5500643&sid=
I dont se link for today's Q3 report from Amarin here:
https://amarincorp.com/news-and-media/amarin-reports-third-quarter-2023-financial-results
https://amarincorp.gcs-web.com/node/23716/pdf
If already linked - no harm done.
ramfan, - Where we are - closing above $ 0ne tomorrow will be just fine 🙂
DM, Please just - 'Go Away' - you are not contributing anything - never have 😭
You are only here when things go bad' - to add salt to the wound. What a sad life you must live 🤡
JR, 197.000 shares - and you I trust - when you say that (contrary to some posters here).
-------------------------------------------
Let me put it like this' - being invested this heavy - that gives you the right to 'be heard' - in your many opinions - even I dont always agree 🙂
I have - 36.000 shares (which for me' far to many). That give me the right to post about 1/6 og you. And that - 'I believe' - is not far of 'the postal facts' !
I were just trying to put a little 'Say' logic in here 🙂
------------------------------------------
Let's hope for a good Amarin Q3 day tomorrow - would be nice for a change.
BBI, Surely everyone is 'spooked' - by the continued fall of SP - who is invested in Amarin.
This is NOT' what we expected would happen after Sarissa takeover control of Amarin.
---------------------------------------
Still I will not today go as far as to say 'a miracle' is needed to change the course of this stock !
But SOMETHING is needed soon - to stop the bleeding / turn the everlasting downslope for investors !
We are running out af dry land to 'stand on' - so we need visible moves to take us' and the Amarin ship into open Waters 🙂
Jroon,
Where is Pfizer ?
They are here (not main focus on Vascepa - sadly)🙂
https://finance.yahoo.com/m/2ff7d0a7-c7f3-3f4a-a62a-e5d2f45f4ae5/pfizer-gets-good-results-from.html
The search for AZ solutions / prevention is on - has been for the last 20- 30 years.
Here the latest Bio Bid on this BIG market from today:
https://finance.yahoo.com/video/eisai-reporting-positive-data-injectable-202940740.html
So it begins - Amarin rebirth under new leadership:
----------------------------------------------
Look at the names:
https://finance.yahoo.com/news/latest-research-evaluating-vascepa-vazkepa-120000060.html
JRoon, You never read the JL version - on how he saw the Nevada ruling from March 2020 ?
----------------------------------
My reasoning of 'the Du character' can be verified in her other 'Show Case' rulings. This lady has a liberal God Complex - looking all the way from Scandinavia.
Just look at another of her 'now famous' rulings:
https://newrepublic.com/article/163419/miranda-du-unconstitutional-immigration-law
----------------------------------
And I dont give a damn if it hurts your intellectual ME TOO feelings, my friend - to be honest 🙂
The Canes, Agreed it is a Dead Horse - but many latecomers here may not know what actually happened after the R-I. Why the huge succes in the trail - ended up being totally mishandled by a management - not understanding the reality of were they were.
Writing the Judge - must be a joke. Marjac tried through all the correct juridical processes - and were (denied) thrown out of Court every time.
As for language - this a anonymous debate board - not diplomacy between states. As long as you get the intention / mening of the post (mostly) I'll live with that 🙂
Jroon, You were not here when JL posted daily !
Informations on background of judge Miranda Du is 'relevant' - as it has to be the only logical reason - a random regional judge 'can lift herself up' to be above and wiser than the experts on bio and drugs at USPTO.
Why something like that is even possibly - that a person not trained in med or bio - can be aloud to 'play God - and totally destroy a Company' - exhibits the disrupted role the Legal system plays in the US.
-------------------------------
But as said here a thousand times: "Why Amarin made a decision to place the 'life threatening' Anda Case in the Ninth Circuit of Nevada" - will forever be on JT and Kennedy !
JRoon, In the immediate reactions following the shocking fraudulent based ruling in Nevada march 2020 - of Vietnamese born - Obama appointed - Female Judge - Miranda Du - (Why on heavens earth choose - NEVADA).
Many experts in this sort of case said' - that Hikma and Ready never expected to Win' - they had to start research and production 'after' the ruling - why it took many months before the first generic IPE were ready.
As for the case itself - this was/is purely routine for them - to run these Anda cases. They were as surprised (shocked) as Amarin when the (ever attention seeking) female Judge - in a single ruling SMASHED the 6 protective patents - that Amarin had used a decade to achieve from the experts in these matters at the USPTO.
--------------------
But Ok - that is all history now.
Truth is Sarissa had never been investing in Amarin - if it weren't for the fraudulent based ruling in Nevada - so these prior disaster events for Amarin ties in to the future of the Company.
There is no rolling back - even Marjac put his entire soul into trying - taking on the US justice system.
Hayward, I were just stating facts - which is surprising - why AMRN has to fall on any sort of 'what is supposed to be' good news.
As most here I fully supported the Sarissa takeover - and stil does.
But It would have been nice to have seen the SP hold up better - not keep falling back - which I'm sure we can all agree on 🙂
All the Brave talk - and our haunted stock falls - how often have we seen that before - all the way from the latest top - when KM were just appointed CEO - SP - $ 6.63 at the top.
$25 - you get my vote. But not likely the sun will shine this bright on Amarin and us all. There is still 5 generic versions out there.
CBB's thoughts on the subject - at best this open the door for the 'big boys' - the right BP's to gain interest in Amarin - BO in not to distant future 🙂
Placing a devil's advokat question here:
Say the Brave study comes out strong - and points to IPE being able to prevent AZ from developing - what is to keep doctors and insurers from prescribing the now 5 generic versions of IPE for their patients ? Up until now nothing and no one has been able to stop the infringing of the CDV label.
Remember from the period after the Nevada fraud based ruling march 2020 - one of the strongest arguments how to stop generic from infringing - were the fact that statistics showed only a smaller fraction of patients need isolated trigs treatment compared to the much greater number of patients at CDV risk. Don't remember the exact percentages - something like 15 - 20% only trigs - rest CDV.
This argument seems to have evaporated into thin air - as the reality have show 'no help from the courts' - infringing of CDV label guaranteed happens bigtime every day in US. And no one from the authorities can do anything about it - or even seems to care.
Simple logic says - that Amarin needs to expand the pipeline 'fast' - to make a Vascepa version 2 (smaller tablets - whatever) that will allow the FDA to separate / stop (once and for all) generics from infringing / stealing Amarins lunch every day.
Easier said than done - I know 🙂
Amarin has officially opened for question - from which a number will be answered on Conference Call november 1 2023.
CBB, Thanks for informing on BNGO - reverse split - didn't know that.
Searched on the issue - and it actually fully illustrates (in real life) that reverse split is in, most cases, the worst possible move to try helping your stock:
https://investorplace.com/2023/08/bngo-stock-alert-bionano-just-reverse-split-its-stock/
Weekend:
Nuke - Ram - and other football fans - here a little 'gold moments in the great sport' - to take your mind of - You Know What 🙂
Capt, Your not alone - Ok on the scale - there can't be many retailers (500 - 600 k - doing a simple headmath on your numbers).
As far as 'doing a normal intelligent investing' - meaning SPREADING - the AMRN stock - and the sad run since March 30 2020 - this stock has completely taken over any kind of sound investment strategy for many of us - me very much included.
Basically - I'm Cash - and AMRN stock. Haven't had the money to take to your level ( 36 k) - but surely if I had' the picture would likely have been similar.
Madness is spreading - just placed orders for 4750 shares if it hits $ 0.70
Meaning tomorrow - we will likely be at $ 0.6xx 🙃
Clearly - AMRN SP were until around september 1. - held above $ 1 - by a floor put under the stock. We have to assume it were Sarissa controlling this' in the market.
Decision were obviously made to 'remove the floor' - and let AMRN float freely in the market which have brought us to the (for long retail investors) rather depressing level we are at today.
---------------------------------
Taking the facts of the matter a bit further - what could possibly be the reason for the development we have seen ?
Beside the fact - that obviously WS do not like the stock much - what options do this 'very low' SP give Sarissa and new BOD of Amarin ?
------------------------------------------
A massive buy back from Amarin - would indicate trust in the future of the Company - say like taking the float down to e.g. 296 mill shares. (below 300). Something like that ought to 'rock the boat'.
Of course Sarissa could be buying shares 'directly' from other Tute shareholders - we dont know - but even the official volume is low - shares could still be in rotation behind the scenes.
-------------------------------------------
Finally - what some posters here use a lot of energy speculating in - Denners motives / morals what have you !
Fact is the guy is a billionaire - from trading stocks in the market - deeply knowledgeable in the science of the Bio market !
You dont use the energy and resources - bring in now 8 specialists in their fields - that Sarissa and Denner has done - in first the long Proxy run - and later total restructuring - saving millions - taking control of the economy of the Company - just for the "plessure of seeing the Company die" !
Even we as shareholders could want to be better/more informed on what are the future plans for Amarin - I personally will never doubt - that there is a reason for CEO Holt and BOD - holding the cards close to the chest - not giving anything away.
JRPAC, Right - Won't be easy beating that one for some time to come 🙂
https://finance.yahoo.com/quote/TPST?p=TPST&.tsrc=fin-srch
Look at volume - this is Reddit numbers - running wild 🙃
Searching for any news directly from Edding Pharma China - fell upon a document - that might be interesting to people with insight in accounting.
What I can see Eding Pharma is doing rather well financially:
https://www1.hkexnews.hk/app/sehk/2023/105474/documents/sehk23062301224.pdf
(In page 11 - some VASEPA informations)
-------------------------------------------------
Under here the official site link:
https://www.eddingpharm.com/EN/index
----------------------------------------
And Of Cause - SP would have to fall today - as it always does on 'Good News' 🙂
JR, I generally disagree with your way of thinking 'analyzing every move AD ever made in business. He is a HF manager - not a sunday Scholl teacher.
Sarissa and the new BOD has been in place for some 6 months - what did you expect 'Miracles' in such a short time ?
Of course it would have been nice SP not being where it is - but my take is that 'it would likely have been the same - or worse - with the old MGT.
What is to me (and the hundred millions of Blue votes) a fact is' - that Sarissa and Denner has a much better chance of 'turning things around for Amarin'.
'This is their speciality / what they do' - recovering value in the undervalued Bio companies they invest in ✌️